JNJ
How Investors Are Reacting To Halozyme Therapeutics (HALO) Hiring Big-Pharma Veteran Darren Snellgrove As CFO
Halozyme Therapeutics recently announced that Darren Snellgrove, a veteran finance leader with more than 30 years of biopharma experience including senior roles at Johnson & Johnson, will become its Chief Financial Officer on June 8, 2026, overseeing financial operations, capital allocation, corporate development, and investor relations. Snellgrove’s background combining investor relations leadership and oversight of a Johnson & Johnson pharmaceuticals business generating over...
Simply Wall St.  ·  May 02, 2026 READ →
NVDA
NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change
As shares of Nvidia (NASDAQ:NVDA) start drifting lower again, interested investors might be able to pick up shares at a reasonable price despite the new innovations that the firm pulled the curtain on in the past several months. Indeed, a lot has happened for Nvidia and Jensen Huang since the new year began. Still, the stock ... NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change
24/7 Wall St.  ·  May 02, 2026 READ →
CAT
CAT Q1 Deep Dive: Data Center Demand and Capacity Expansion Drive Strong Results
Construction equipment company Caterpillar (NYSE:CAT) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 22.2% year on year to $17.42 billion. Its non-GAAP profit of $5.54 per share was 19.3% above analysts’ consensus estimates.
StockStory  ·  May 02, 2026 READ →
NVDA
Infleqtion Went Public in February -- Here's Why This Cold Atom Stock Could Be a Breakout Buy
The quantum sensor and timing device maker deserves more attention.
Motley Fool  ·  May 02, 2026 READ →
INTC
Infleqtion Went Public in February -- Here's Why This Cold Atom Stock Could Be a Breakout Buy
The quantum sensor and timing device maker deserves more attention.
Motley Fool  ·  May 02, 2026 READ →
NVDA
Amazon Just Proved It's No Longer an AI Underdog
AWS continues to show accelerated revenue growth.
Motley Fool  ·  May 02, 2026 READ →
INTC
Amazon Just Proved It's No Longer an AI Underdog
AWS continues to show accelerated revenue growth.
Motley Fool  ·  May 02, 2026 READ →
AMZN
Amazon Just Proved It's No Longer an AI Underdog
AWS continues to show accelerated revenue growth.
Motley Fool  ·  May 02, 2026 READ →
NVDA
EDIV’s 24% Rally Masks a Dividend Trap for Income Seekers
SPDR S&P Emerging Markets Dividend ETF (NYSEARCA:EDIV) has quietly put together a strong run, with shares up about 24% over the past year and about 7% year-to-date through April 17, 2026. For income-focused investors, the question is whether the distributions backing that yield are durable or whether the fund’s structure introduces more risk than the ... EDIV’s 24% Rally Masks a Dividend Trap for Income Seekers
24/7 Wall St.  ·  May 02, 2026 READ →
NVDA
Watch These 3 Contract Signals Before EUAD’s Next Move
Select STOXX Europe Aerospace & Defense ETF (NASDAQ:EUAD) was the cleanest way to own European defense stocks from a U.S. brokerage account in 2025. The fund launched by Tuttle Capital Management on October 22, 2024 solves a simple problem: U.S. investors wanting concentrated exposure to Airbus, BAE Systems, Rheinmetall, Leonardo, and Europe’s prime contractors had ... Watch These 3 Contract Signals Before EUAD’s Next Move
24/7 Wall St.  ·  May 02, 2026 READ →
INTC
Forget Hyperliquid: High Beta, Low Conviction
This little token is still too hot to handle.
Motley Fool  ·  May 02, 2026 READ →
NVDA
Forget Hyperliquid: High Beta, Low Conviction
This little token is still too hot to handle.
Motley Fool  ·  May 02, 2026 READ →